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be used systematically.” Conclusions regarding the value of revas-
cularization can clearly not be deduced from a study of only
revascularized patients, especially if one considers the high re-
ported rate of recurrent ventricular arrhythmias despite routine
revascularization (i.e., 32/62 5 58%). Great caution must be
exerted in interpreting the reported data to avoid unfounded
conclusions and their important implications.
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REPLY
We appreciate Dr. Khairy’s interest in our article recently pub-
lished in the Journal of the American College of Cardiology.
Dr. Khairy argues that some methodologic aspects of the work
are questionable. The objective of our study was not to investigate
independent factors predictive of recurrent events during follow-
up, but rather to compare several variables between those having or
not having recurrent events. In that case, and owing to the limited
number of patients, a univariate analysis seems correct.
Our report is an observational study in a very specific patient
population with limited information on the literature so far. We
never intended to investigate the value of revascularization or
antiarrhythmic therapy in such a population. The objective was to
report that the combined approach gives excellent results in terms
of survival (compared to historical series), and that revasculariza-
tion alone does not prevent arrhythmic recurrences.
The conclusion that an individualized combined approach gives
excellent results and should be used systematically seems reason-
able. In patients with a clear indication for revascularization and
who have suffered clinically sustained ventricular arrhythmias, a
randomized study using different combinations of revascularization
yes or no and antiarrhythmic therapy yes or no would probably be
methodologically correct but certainly ethically incorrect.
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Management of Anomalous Coronary Artery
The Davis et al. (1) finding of a 0.17% prevalence of anomalous
coronary artery from the wrong aortic sinus in an asymptomatic
pediatric population is important data. These investigators and
others (2) suggest that surgical management is mandatory, while
admitting that the duration of coronary artery bypass graft surgery
(CABG) patency is not known. The accompanying editorial is
more cautious for asymptomatic patients ,35 years of age, citing
uncertainty surrounding the most appropriate management option
and stating that “surgical repair should be considered” (3). Pelliccia
(3) also believes that these lesions in patients .35 years of age have
“likely no clinical significance” and “most probably [need] no
surgical treatment.”
I am concerned that the specter of sudden death seems to have
compelled many to “do something,” in the absence of good
outcomes data. A prevalence of ;0.1% to 0.2% among ;4 million
live births annually in the U.S. (4) yields about 4,000 to 8,000
children born each year with these coronary anomalies. Of 275
million people in the U.S. (assuming a low incidence of death),
;275,000 to 550,000 would be affected; approximately half are
under age 35. (As an aside, the risk in an adult over age 35 may not
be insignificant, as a recent case report shows [5].) And yet, the
number of cases of sudden death appears exceedingly small when
compared with these population figures (,,1%), as data from U.S.
and Italian registries suggest (2). Is this truly the natural history of
these lesions, or are we underestimating the risk?
The CABG procedure is not risk-free (6,7). Admittedly, surgi-
cal risk is likely to be lower in patients with anomalous coronary
artery from the wrong sinus than with other coronary problems, as
patients are typically healthy. Nevertheless, even the simplest of
pediatric heart operations carry risks of neurologic, myocardial, and
other organ injury, as well as death. Moreover, surgical “repair” by
no means guarantees cure. One recent study of children showed
patency rates of 78% and 36% for internal mammary grafts and
saphenous vein grafts, respectively, at 10 years (7). Such figures
virtually guarantee reoperation in most patients, with its concom-
itant risks.
Some physicians and families may prefer to accept the surgical
risks rather than to live with an unknown potential for sudden
death, but these risks must be fully understood before an operation
is undertaken. I do believe that activity can often be modified, and
therefore risk can be reduced, even if not eliminated. But the
unanswered questions remain: 1) What is the true natural history
of these coronary anomalies? 2) What is the long-term “unnatural
history” of CABG in children? Although sudden death, particu-
larly in a young and seemingly healthy person, is especially tragic,
we must remember the fundamental principle of primum non
nocere—“first, do no harm.” Therefore, when it comes to surgical
management, one must consider the adage, however difficult:
“Don’t just do something, stand there!”
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